Q32 Bio Inc. Files 8-K on Security Holder Rights & Bylaws
Ticker: QTTB · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1661998
| Field | Detail |
|---|---|
| Company | Q32 Bio Inc. (QTTB) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, legal-update
TL;DR
Q32 Bio filed an 8-K detailing changes to security holder rights and corporate governance.
AI Summary
Q32 Bio Inc. filed an 8-K on June 17, 2025, reporting material modifications to security holder rights, amendments to its articles of incorporation, and the submission of matters to a vote of security holders. The filing also includes financial statements and exhibits related to events on June 13, 2025. The company, formerly known as Homology Medicines, Inc., is incorporated in Delaware and based in Waltham, MA.
Why It Matters
This 8-K filing indicates significant corporate actions by Q32 Bio Inc., potentially impacting the rights and governance structure for its security holders.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and amendments to governing documents can introduce new risks or alter existing ones for investors.
Key Numbers
- 001-38433 — SEC File Number (Identifies the company's filing history with the SEC)
- 47-3468154 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Q32 Bio Inc. (company) — Registrant
- Homology Medicines, Inc. (company) — Former company name
- June 13, 2025 (date) — Earliest event reported
- June 17, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Waltham, Massachusetts (location) — Principal executive offices
FAQ
What specific material modifications were made to the rights of security holders?
The filing indicates 'Material Modifications to Rights of Security Holders' as an item information, but the specific details of these modifications are not provided in the excerpt.
What were the key amendments to Q32 Bio Inc.'s articles of incorporation or bylaws?
The filing lists 'Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year' as an item information, but the specific amendments are not detailed in the provided text.
What matters were submitted to a vote of security holders?
The filing states 'Submission of Matters to a Vote of Security Holders' as an item information, but the specific matters are not enumerated in the excerpt.
When did Q32 Bio Inc. change its name from Homology Medicines, Inc.?
The filing indicates the former company name was Homology Medicines, Inc. and the date of name change was December 28, 2015.
What is the principal business address of Q32 Bio Inc.?
The principal executive offices are located at 830 Winter Street, Waltham, Massachusetts, 02451.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding Q32 Bio Inc. (QTTB).